In the Media

Researchers from MIT and other institutions have uncovered “new pathways, along with identifying genes, that may contribute to the development of a new class of drugs” to treat Alzheimer’s disease, reports John R. Ellement for The Boston Globe. “The drugs currently approved to treat Alzheimer’s have not been as successful as hoped,” Ellement explains. “Those drugs tend to target amyloid plaques in the brain, but the new research suggests other areas to target.”